APA (7th ed.) Citation

SL, D., A, A., R, A., IA, C., CR, D., C, F., . . . Y, X. (2020). Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors. Bioorganic & medicinal chemistry, 28(23), 115815. https://doi.org/10.1016/j.bmc.2020.115815

Chicago Style (17th ed.) Citation

SL, Degorce, et al. "Improving Metabolic Stability and Removing Aldehyde Oxidase Liability in a 5-azaquinazoline Series of IRAK4 Inhibitors." Bioorganic & Medicinal Chemistry 28, no. 23 (2020): 115815. https://doi.org/10.1016/j.bmc.2020.115815.

MLA (9th ed.) Citation

SL, Degorce, et al. "Improving Metabolic Stability and Removing Aldehyde Oxidase Liability in a 5-azaquinazoline Series of IRAK4 Inhibitors." Bioorganic & Medicinal Chemistry, vol. 28, no. 23, 2020, p. 115815, https://doi.org/10.1016/j.bmc.2020.115815.